86.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$87.26
Aprire:
$87.26
Volume 24 ore:
151.32K
Relative Volume:
0.91
Capitalizzazione di mercato:
$1.97B
Reddito:
$213.03M
Utile/perdita netta:
$41.32M
Rapporto P/E:
47.45
EPS:
1.83
Flusso di cassa netto:
$33.49M
1 W Prestazione:
-0.58%
1M Prestazione:
-6.10%
6M Prestazione:
+2.53%
1 anno Prestazione:
-5.15%
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Nome
Lemaitre Vascular Inc
Settore
Industria
Telefono
781-221-2266
Indirizzo
63 SECOND AVENUE, BURLINGTON, MA
Confronta LMAT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
LMAT
Lemaitre Vascular Inc
|
86.84 | 1.98B | 213.03M | 41.32M | 33.49M | 1.83 |
![]()
ISRG
Intuitive Surgical Inc
|
434.62 | 156.44B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
185.29 | 53.99B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
270.09 | 39.41B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
75.39 | 36.63B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
267.19 | 18.78B | 2.96B | 487.70M | 344.00M | 6.6758 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-08-06 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2025-02-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2025-02-28 | Downgrade | Oppenheimer | Outperform → Perform |
2025-02-13 | Iniziato | Wells Fargo | Equal Weight |
2024-10-15 | Iniziato | Cantor Fitzgerald | Neutral |
2024-08-02 | Ripresa | Lake Street | Buy |
2024-05-31 | Ripresa | ROTH MKM | Buy |
2024-04-26 | Aggiornamento | Stifel | Hold → Buy |
2024-02-06 | Ripresa | KeyBanc Capital Markets | Sector Weight |
2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
2023-09-06 | Iniziato | Oppenheimer | Outperform |
2023-08-03 | Downgrade | Jefferies | Buy → Hold |
2023-05-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2022-10-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2021-09-16 | Iniziato | Jefferies | Buy |
2021-02-12 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2020-03-16 | Aggiornamento | Sidoti | Neutral → Buy |
2019-10-24 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
2019-10-24 | Aggiornamento | Lake Street | Hold → Buy |
2019-10-14 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
2019-07-25 | Reiterato | Barrington Research | Outperform |
2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
2018-10-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2018-10-08 | Aggiornamento | ROTH Capital | Neutral → Buy |
2018-06-08 | Ripresa | ROTH Capital | Buy |
2018-04-26 | Downgrade | Stifel | Buy → Hold |
2018-04-26 | Aggiornamento | The Benchmark Company | Hold → Buy |
2017-10-27 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
2017-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
2017-07-10 | Downgrade | Canaccord Genuity | Buy → Hold |
2017-07-10 | Downgrade | The Benchmark Company | Buy → Hold |
2017-03-21 | Iniziato | First Analysis Sec | Overweight |
2017-02-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2016-09-22 | Downgrade | Sidoti | Buy → Neutral |
2016-07-28 | Reiterato | Barrington Research | Outperform |
2016-02-25 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie
Best data tools to analyze LeMaitre Vascular Inc. stockPortfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
Signal strength of LeMaitre Vascular Inc. stock in tech scanners2025 AllTime Highs & Technical Confirmation Alerts - newser.com
Volatility clustering patterns for LeMaitre Vascular Inc.Watch List & Real-Time Market Sentiment Reports - newser.com
LeMaitre Vascular (LMAT) Analyst Ratings Unchanged by Barrington Research | LMAT Stock News - GuruFocus
LeMaitre Vascular's (LMAT) Outperform Rating Reaffirmed at Barrington Research - MarketBeat
What MACD and RSI say about LeMaitre Vascular Inc.2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
Vest Financial LLC Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Detecting price anomalies in LeMaitre Vascular Inc. with AIIndex Update & Technical Pattern Based Buy Signals - newser.com
Is a relief rally coming for LeMaitre Vascular Inc. holdersDollar Strength & Fast Moving Stock Trade Plans - newser.com
Smart tools for monitoring LeMaitre Vascular Inc.’s price action2025 Bull vs Bear & Growth-Oriented Investment Plans - newser.com
Using data models to predict LeMaitre Vascular Inc. stock movementIndex Update & Risk Controlled Swing Trade Alerts - newser.com
How hedge fund analytics apply to LeMaitre Vascular Inc. stock2025 Retail Activity & Precise Swing Trade Entry Alerts - newser.com
When is the best time to exit LeMaitre Vascular Inc.Trade Signal Summary & Expert Approved Momentum Ideas - newser.com
Published on: 2025-10-12 21:02:34 - newser.com
Published on: 2025-10-12 10:19:29 - newser.com
How LeMaitre Vascular Inc. (LHU) stock reacts to Fed tighteningJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
LeMaitre Vascular (LMAT): How a Strong Q2 and Raised Guidance Are Shaping Its Valuation Outlook - Sahm
LeMaitre Vascular (NASDAQ:LMAT) Earns Buy (B-) Rating from Weiss Ratings - MarketBeat
What technical models suggest about LeMaitre Vascular Inc.’s comeback2025 Valuation Update & Long-Term Growth Stock Strategies - newser.com
LeMaitre Vascular, Inc. Announces Third Quarter 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025 - The Manila Times
Nov 6: LeMaitre Vascular to Announce Third-Quarter 2025 Results; Conference Call 5:00 PM EST - Stock Titan
The Bull Case for LeMaitre Vascular (LMAT) Could Change Following Raised 2025 Guidance and Strong Q2 Results - Sahm
What’s next for LeMaitre Vascular Inc. stock priceWeekly Gains Summary & Risk Managed Trade Strategies - newser.com
What MACD signals say about LeMaitre Vascular Inc.2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Is now a turning point for LeMaitre Vascular Inc.2025 Support & Resistance & Free Technical Pattern Based Buy Signals - newser.com
Is LeMaitre Vascular Inc. forming a bottoming base2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Is LeMaitre Vascular Inc LHU a good long term investmentBollinger Bands Signals & Access Free Tools and Start Investing - earlytimes.in
Financial Review: LeMaitre Vascular (NASDAQ:LMAT) and Ingen Technologies (OTCMKTS:IGNT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $97.60 Consensus Price Target from Analysts - Defense World
Surgical Equipment & ConsumablesSpecialty Stocks Q2 Earnings Review: LeMaitre (NASDAQ:LMAT) Shines - Yahoo Finance
LeMaitre Vascular Inc. stock chart pattern explainedJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
LeMaitre Vascular (LMAT): Unpacking Current Valuation After Steady Share Performance - Yahoo Finance
State of Alaska Department of Revenue Boosts Stock Holdings in LeMaitre Vascular, Inc. $LMAT - Defense World
10,744 Shares in LeMaitre Vascular, Inc. $LMAT Purchased by Public Employees Retirement System of Ohio - Defense World
Analyzing LeMaitre Vascular Inc. with risk reward ratio chartsJuly 2025 Decliners & Community Consensus Picks - newser.com
Multi asset correlation models including LeMaitre Vascular Inc.2025 Major Catalysts & Smart Allocation Stock Tips - newser.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Copeland Capital Management LLC Sells 88,686 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lemaitre Vascular Inc Azioni (LMAT) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Roberts David B | President and Director |
Aug 11 '25 |
Option Exercise |
37.27 |
10,815 |
403,069 |
24,689 |
Roberts David B | President and Director |
Aug 11 '25 |
Sale |
92.39 |
10,815 |
999,173 |
17,976 |
Ross Bridget A | Director |
Aug 08 '25 |
Option Exercise |
37.29 |
2,500 |
93,225 |
5,416 |
Ross Bridget A | Director |
Aug 08 '25 |
Sale |
94.00 |
2,500 |
235,000 |
2,916 |
Roush John A | Director |
Aug 11 '25 |
Option Exercise |
37.29 |
6,561 |
244,660 |
9,477 |
Roush John A | Director |
Aug 08 '25 |
Option Exercise |
37.29 |
939 |
35,015 |
3,855 |
Roush John A | Director |
Aug 11 '25 |
Sale |
92.55 |
6,561 |
607,231 |
2,916 |
Roush John A | Director |
Aug 08 '25 |
Sale |
93.49 |
939 |
87,784 |
2,916 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):